Utah Medical Products reported $46.29M in Cash and Equivalent for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Angiodynamics ANGO:US $ 58.02M 10.1M
Antares Pharma ATRS:US $ 50.17M 6.61M
Cerulean Pharma CERU:US $ 5.39M 0.04M
Cerus CERS:US $ 28.95M 5.95M
General Electric GE:US $ 36630M 2532M
Integra Lifesciences IART:US $ 470.17M 73.89M
Orasure Technologies OSUR:US $ 162.86M 11.02M
Rockwell Medical RMTI:US $ 56.61M 29.92M
Sientra SIEN:US $ 63.48M 8.32M
Staar Surgical STAA:US $ 152.45M 24.12M
Stryker SYK:US $ 2943M 4140M
Utah Medical Products UTMD:US $ 46.29M 3.94M
West Pharmaceutical Services WST:US $ 615.5M 96.1M